AdventHealth Manchester is First in Region to Offer New, More Comfortable Mammogram

Published date: |
Estimated read time: |
Authored by:
  • Christina Couch
A woman talks with her doctor before an imaging test.
Choose the health content that's right for you, and get it delivered right in your inbox

Manchester, Kentucky November 11, 2019 — AdventHealth Manchester is first in region to offer the SmartCurve™ breast stabilization system, which is clinically proven to deliver a more comfortable mammogram without compromising image quality, workflow or dose.[i] This latest innovation is part of AdventHealth’s ongoing commitment to superior breast cancer detection and has the potential to increase screening volume and compliance for the countless women who have reported avoiding regular mammograms due in large part to the fear of discomfort associated with breast compression.

The SmartCurve system is available exclusively with Hologic’s Genius 3D Mammography exam, which is currently in use by AdventHealth Manchester and detects more invasive cancers, reduce false positives, and is FDA approved as superior to conventional 2D mammography for all women, including those with dense breasts.[ii],[iii],[iv]

“With this new technology, we are not only able to provide a more comfortable mammogram, but can do so while maintaining clinical accuracy, which is key,” said Chris Carnes, Diagnostic Imaging Manager. "I'm hopeful that with the addition of the SmartCurve system, we’ll be able to lessen the pain and anxiety associated with mammograms and, as a result, increase screening compliance.”

The SmartCurve system features a proprietary curved surface that mirrors the shape of a woman’s breast to reduce pinching and allow better distribution of force over the entire breast. In a recent clinical study comparing the SmartCurve breast stabilization system to traditional flat paddle compression, the SmartCurve system improved comfort in 93 percent of women who reported moderate to severe discomfort with standard compression.1 In addition, 95 percent of those surveyed would recommend facilities that use the system.1

“We’re excited to provide this first-of-its-kind technology to our patients and remain committed to offering the women of our community the best breast care possible,” added Dr. Utpal Bhanja, Oncologist at AdventHealth Manchester.

For more information about AdventHealth Manchester and its breast health services, visit https://www.adventhealth.com/hospital/adventhealth-manchester/imaging-services.

About Hologic

Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.

Hologic, SmartCurve, Genius, 3D and 3D Mammography and associated logos are trademarks and/or registered trademarks of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries.

[1] Smith, A. Improving Patient Comfort in Mammography. Hologic WP-00119 Rev 003 (2017).

[1] Results from Friedewald, SM, et al. "Breast cancer screening using tomosynthesis in combination with digital mammography." JAMA 311.24 (2014): 2499-2507; a multi-site (13), non-randomized, historical control study of 454,000 screening mammograms investigating the initial impact the introduction of the Hologic Selenia® Dimensions ® on screening outcomes. Individual results may vary. The study found an average 41% (95% CI: 20-65%) increase and that 1.2 (95% CI: 0.8-1.6) additional invasive breast cancers per 1000 screening exams were found in women receiving combined 2D FFDM and 3DÔ mammograms acquired with the Hologic 3D Mammography system versus women receiving 2D FFDM mammograms only.

[1] Bernardi D, Macaskill P, Pellegrini M, et. al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13.

[1] U.S. Food & Drug Administration Premarket Approval (PMA). FDA.gov https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P080003 accessed June 5, 2017.

About AdventHealth Manchester

AdventHealth Manchester is a 49-bed, acute care, not-for-profit, Christian, community hospital that serves Clay county and its surrounding areas. As a part of AdventHealth’s connected system of care, AdventHealth Manchester provides whole-person care for its community. With a sacred mission of Extending the Healing Ministry of Christ, AdventHealth is a connected system of care for every stage of life and health. More than 80,000 skilled and compassionate caregivers in physician practices, hospitals, outpatient clinics, skilled nursing facilities, home health agencies, and hospice centers provide individualized, wholistic care. A shared vision, common values, focus on whole-person health and commitment to making communities healthier unify the system's nearly 50 hospital campuses and hundreds of care sites in diverse markets throughout almost a dozen states. For more information about AdventHealth, visit AdventHealth.com, or Facebook.com/AdventHealth.

###

Recent News